CARD8 (TUCAN) is implicated in the regulation of apoptosis and inflammation, and is a positional and functional candidate gene for inflammatory bowel disease (IBD). Recent investigations have reported conflicting results of association between a CARD8 nonsynonymous SNP, rs2043211, and IBD. SNP rs2043211 results in an A4T transversion in the CARD8 template strand, which introduces a stop codon polymorphism (Cys10Stop), and genotyping of the Cys10Stop variant revealed that 9% of the control population was homozygous for the 'Stop' allele. The effect of the Stop allele on mRNA and protein expression of the two known isoforms of this gene was investigated. IBD patients homozygous for the Stop allele showed somewhat reduced expression of CARD8 mRNA, but, contrary to expectation, expressed a 48 kDa protein isoform. A search of the EST database and reverse transcription-PCR analysis revealed a novel coding exon and three novel CARD8 mRNA isoforms that are conserved in primates. The isoforms of CARD8 differ in their N-termini, resulting in diverse predicted molecular weights (47, 48, 51, 54 and 60 kDa) and multiple outcomes for the variant including Cys10Stop, Cys34Stop, Phe52Ile and Phe102Ile; one isoform may arise through transcription and translation initiated downstream of rs2043211 to yield a novel protein isoform of B47 kDa. The multiple isoforms and differing consequences for a predicted stop codon polymorphism underline the importance of detailed analysis of the effects of proposed functional variants on gene expression.
Introduction
The caspase-associated recruitment domain (CARD) is a protein -protein interaction motif found in a wide range of proteins primarily involved in the regulation of apoptosis and NF-kB signalling.
1 CARD-containing proteins regulate apoptosis through direct interactions with caspase proteins, and modulate the expression of genes involved in inflammation through regulation of the NF-kB pathway. CARD15/NOD2 activates NF-kB in response to the peptidoglycan component of bacterial cell walls through its ligand muramyl dipeptide, and CARD15 mutations that disrupt this response are associated with Crohn's disease (CD). 2 -4 Another CARD-containing protein, CARD8, also named TUCAN (tumour-upregulated CARD-containing antagonist of caspase-9) or CARDINAL, is implicated in the regulation of both apoptosis and inflammation, and is known to undergo differential splicing leading to at least two protein isoforms. 5 -8 A 48 kDa isoform (T48) expressed mainly in monocytes, placenta, lymph nodes and spleen 8 interacts directly with caspase-1 and can induce apoptosis, whereas a larger 54 kDa isoform (T54) is overexpressed in some cancers and suppresses caspase-mediated apoptosis. 8 CARD8 also interacts with IKKg/NEMO, leading to inhibition of NF-kB activity. 7 Its gene maps to a region that has shown linkage to inflammatory bowel disease (IBD) in several genome-wide linkage scans, 9 -12 confirmed in a metaanalysis of 10 genome-wide linkage studies. 13 The CARD8/TUCAN protein is encoded by the 13 exons of the CARD8 gene on chromosome 19q13. The two known isoforms of the protein have different transcription and translation initiation sites. The open reading frame (ORF) of T48 starts in exon 5 and encodes 432 amino acids, while the ORF of T54 starts in exon 4 and encodes 487 amino acids (see Figure 1 ). The N-termini of the resulting polypeptide sequences differ up to exon 7, after which both proteins have the same ORF and share the remaining 398 amino acids. The underlying cause of these differences is that the T48 transcript lacks the frame-shifting coding exon 6 of T54 (see Figure 1 ). The C-terminal CARD domain is present in both isoforms. The finding that 9% of the control population was homozygous for the Stop allele and would therefore be predicted to lack a functional T48 protein was unexpected. This, together with the evidence for the T54 isoform, led us to a more detailed investigation of the expression of CARD8, which revealed a series of isoforms that impact on the functional consequences of the rs2043211 SNP.
Materials and methods
Reverse transcription PCR Total RNA was isolated from lymphoblastoid cell lines of CD patients of known rs2043211 genotype, monocyte cell line THP1 and fresh peripheral blood lymphocytes from normal individuals, using RNA Isolator (Genosys, Cambridge, UK). Total RNA from ascending colon, duodenum and adult breast tissue was purchased from Stratagene (La Jolla, CA, USA). All RNA samples were quantified using an Agilent 2100 Bioanalyzer. Five hundred nanograms of RNA was heat denatured at 701C for 5 min with 0.5 mg oligo-dT primer (Invitrogen, Paisley, UK) in a final volume of 20 ml and then chilled on ice. Reverse transcription was performed at 421C for 1 h using 50 U M-MLV reverse transcriptase (Ambion, Huntingdon, UK), 3 ml 10 Â first strand buffer, 10 U RNase inhibitor (Promega, Southampton, UK) and 0.5 mM each dNTP in a final volume of 30 ml. Five microlitre aliquots of cDNA were PCR amplified using 5 U Amplitaq Gold s DNA polymerase (Applied Biosystems, Warrington, UK), 2 ml 10 Â reaction buffer, 1.5 mM MgCl 2 , 0.5 mM each dNTP and 40 ng each oligonucleotide primer in a final volume of 20 ml. Primers for reverse transcription (RT)-PCR amplification are shown in Supplementary Table 1. Reactions were heat denatured at 951C for 10 min followed by 40 cycles of 951C for 30 s, 651C for 30 s, 721C for 1 min.
DNA sequencing
Gel-purified RT-PCR products were sequenced using the BigDye v3.1 dye terminator kit (Applied Biosystems) according to the manufacturer's instructions, and analysed on an ABI 3730XL automated DNA sequencer.
Western blots
Frozen or fresh cultured cell pellets were lysed on ice in 20 mM Na 3 PO 4 (pH 7.4), 1% SDS and Completet protease inhibitor cocktail (Roche Diagnostics, Basel, Switzerland) and clarified at 13 000 r.p.m. for 10 min. Protein concentrations were determined using a BCA Protein Assay Kit (Perbio Science, Cramlington, UK). Fifty micrograms of protein was boiled in 80 mM Tris-HCl (pH 8.0), 4% glycerol, 0.2% SDS, 25% 2-mercaptoethanol and 0.2 mg/ml bromophenol blue and resolved through a 12.5% SDS-PAGE gel for 1.5 h at 150 V, then transferred to Hybond-ECL (Amersham Biosciences, Buckinghamshire, UK). The membrane was incubated at room temperature in PBS containing 5% non-fat milk for 1 h, followed by PBS containing 5% non-fat milk and rabbit anti-TUCAN (CARD8) antibody at 41C overnight. The TUCAN/CARD8 antibody was raised against residues 99 -115 of T54 (encoded by part of exon 7). 8 The membrane was washed in PBS and incubated for 1 h at 41C in PBS containing 5% non-fat milk and anti-mouse IgG antibody (Dako, Stockholm, Sweden), washed in PBS and incubated with the ECL detection kit (Amersham Biosciences). Chemiluminescence was visualised using Hyperfilm ECL (Amersham Biosciences).
Results
The rs2043211 A4T transversion in exon 5 of CARD8 results in a predicted Cys4Stop at codon 10 in T48 and a Phe4Ile amino-acid substitution at codon 52 in T54. These two outcomes are likely to have different effects on the stability and structure of the T48 and T54 mRNA isoforms, as premature termination codons can target mRNAs for degradation via nonsense-mediated decay 18 and can cause skipping of the exon containing the nonsense mutation. 19 We therefore used the primer pair TUCAN-EX5-F in exon 5 and TUCAN-EX9-R in exon 9 ( Figure 1 ), which direct amplification of a 531 and 571 bp product from T48 and T54 cDNA, respectively (the size difference reflects the exclusion or inclusion of exon 6), to investigate the expression of both TUCAN mRNA isoforms in different tissues, and in lymphoblastoid cell lines of CD patients who were homozygous for the presence or absence of the Stop allele or heterozygous. T48 and T54 mRNAs were expressed in all tissues examined ( Figure 2 ) and the expression of T48 and T54 in CD patients homozygous for the Stop allele (TT; 939 and 090) could be seen in patients homozygous for the Cys allele (AA; 388 and 435). The expression of individual mRNA isoforms was further investigated using the primer TUCAN-EX9-R in exon 9 with the forward primers TUCAN-54F or TUCAN-48F, which, by traversing exon boundaries, specifically amplify T54 and T48 cDNA, respectively (Figure 1 ). In keeping with our previous results, expression of T54 mRNA was similar in CD patients, irrespective of rs2043211 genotype status (Figure 2) . Expression of the T48 isoform was somewhat lower relative to GAPDH in patients homozygous for the Stop allele ( Figure 2 ). This suggests that this stop codon, contrary to expectations, may not induce significant nonsensemediated decay in T48 transcripts, although the RT-PCR technique used here is at best semi-quantitative and, therefore, this observation requires further confirmation.
We also investigated the possibility that exon 5, which contains rs2043211, might be skipped in some T54 transcripts, as this could generate an in-frame mRNA and translation product of B48 kDa. Amplification of T54 and T48 mRNA using a forward primer in exon 4 and a reverse primer in exon 9 failed to yield any transcripts lacking exon 5, regardless of genotype, indicating that rs2043211 does not lead to exon skipping (results not shown).
The two known transcripts of CARD8, together with western blots showing its encoded protein migrating as a broad band or as a doublet, 6 provide evidence of multiple protein isoforms. To assess the full isoform diversity of the N-terminus of CARD8, we analysed the structure of sequences in the human section of the expressed sequence tag (EST) database (dbEST, October 2006) identified by a BLASTN search using exons 4 -7 of T54. Of the 69 cognate ESTs, 43 were fully informative for transcript structure in this region (Supplementary Table 2 ). Seven ESTs retain exon 6 and correspond to T54, whereas 20 ESTs skip exon 6 and correspond to T48. Interestingly, a further seven and three ESTs resemble T54 and T48 transcripts, respectively, but contain an additional 150 bp exon between exons 4 and 5 (AC011466: 155973 -156122), which is not described by either Yamamoto et al 8 or Razmara et al. 20 The ORFs and splice sites are conserved in chimpanzee, orangutan and macaque, and this exon appears in the single orangutan (CR547228) and macaque (CJ459175) ESTs. As confirmation, RT-PCR amplification between exons 4 (TUCAN-EX4-F) and 9 (TUCAN-EX9-R) amplified the expected 590 and 631 bp products of T48 and T54, respectively, and further 740 and 781 bp products (see Figure 3a ), which we found by sequencing to correspond to T48 and T54 transcripts containing this additional exon. This would insert 50 amino acids (B6 kDa) after residue 21 in the canonical T54 protein, yielding a novel protein, which we call T60 (EU118120), and would add a potential in-frame translation initiation codon 24 amino-acid residues upstream of the canonical T48 start codon to produce a protein of 51 kDa, which we call T51 (EU118121) (Figure 1 ). We have denoted this new exon as 'exon 4a' to maintain the published exon numbering. Further examination of the human ESTs yielded the surprising result that six ESTs start within intron 5 (BF091373, BE168871, BE168868, BE168799, BI827664 and BG118619). These transcripts could arise from a promoter within this 1.9-kb intron, with the longest EST (BI827664) starting B400 bp upstream of exon 6. A search for human promoter sequences in intron 5 using the webbased 'core promoter' program (http://rulai.cshl.edu/tools/ genefinder/CPROMOTER/human.htm) revealed a putative transcription start site 375 bp upstream of exon 6. There is a potential translation initiation codon 20 bp upstream of exon 6, which is in a good Kozak context in-frame with the T54 and T60 ORF; this is conserved in chimpanzee, orangutan, rhesus monkey and marmoset. This would provide seven N-terminal amino acids before joining the exon 6 sequence to generate a putative protein isoform of 47.5 kDa, which we call T47 (EU118122) (Figure 1 , Supplementary Table 2 ). T47would differ from T48 only at its N-terminus, where the first 25 amino acids of T48 would be replaced by 20 new ones in T47 (Supplementary Figure 1) . A conserved T47 cDNA has been isolated from the orangutan (CR858904) and has been predicted from the chimpanzee CARD8 genomic sequence (XP_001170446). We sought to confirm the existence of the T47 transcript in humans by RT-PCR using a forward primer in intron 5 (TUCAN-47F), 104 bp upstream of exon 6, paired with a reverse primer in exon 9 (TUCAN-EX9-R); this amplified a 547 bp product (Figure 3b ) and sequencing confirmed the expected sequence (data not shown). Thus, the prediction from the EST population alone is that T48 should be the most prevalent isoform, with less prevalent isoforms of T60, T54, T51 and T47 (Figure 1, Supplementary Table 2) .
The various isoforms of CARD8 differ only in their N-termini, and thus the rs2043211 SNP would cause a different outcome in each isoform; Cys10Stop in T48, Cys34Stop in T51, Phe52Ile in T54, Phe102Ile in T60 and, as transcription of T47 starts downstream of rs2043211, the sequence of the T47 isoform would be unaffected (Figure 1,  Supplementary Figure 1) .
In keeping with our analysis of the EST database, western analysis has previously shown that the predominant CARD8 isoform expressed in normal cells is B48 kDa. 7 The Cys4Stop polymorphism is predicted to generate a severely truncated protein comprising the first nine amino acids of T48 followed by a translation stop codon; thus, individuals homozygous for the Stop allele would be expected to lack the T48 isoform. We investigated expression of the protein in lymphoblastoid cell lines of CD patients of the three possible Cys10Stop genotypes (AA, AT and TT or Cys/Cys, 'Cys/Stop' and 'Stop/Stop' respectively), using a polyclonal antibody raised against a peptide sequence common to all isoforms, encoded by part of exon 7. The MCF7 and K562 cell lines, which are AA (Cys/Cys) and AT (Cys/Stop) for rs2043211, respectively, were used as positive controls for the presence of T48, as both have previously been shown to express T48, with the former showing particularly high level expression. 6 The cell lines MCF7 and K562, and CD patients who were also AA (Cys/Cys) or AT (Cys/Stop) at rs2043211, revealed an immunoreactive band of B48kDa; however, contrary to our initial expectations, so did patients who were homozygous for the Stop allele (Figure 4 ). In the light of the mRNA isoforms described above, this band may instead represent T47, which is only five amino acids shorter than the canonical T48 isoform and is unlikely to be resolved from it on the western blot. Interestingly, the lymphoblastoid cell line of one patient homozygous for the Stop allele showed an additional band of B54 kDa. A formal possibility remains that skipping of downstream inframe exons 10 and 12 from T54 transcripts could generate a protein of B48 kDa. This was investigated by sequencing cDNA amplification products from exons 9 to 13, but no skipping of these downstream exons was observed. 
Discussion
Our investigation of the EST database together with confirmatory RT-PCR analysis has revealed a novel coding exon and three novel mRNA isoforms of CARD8, which, like the two previously described isoforms, differ in their N-terminal residues but contain an identical C-terminal CARD domain. SNP rs2043211, for which there is conflicting evidence for an association with IBD, has different outcomes in the various isoforms, resulting in either a nonsense polymorphism or amino-acid substitution within the variable N-terminal regions. The variant outcomes affect not only the sequence of translated amino acids but also the stability of the mRNA isoforms. In keeping with previous observations, RT-PCR amplification in various tissues showed that the two known CARD8 mRNA isoforms are widely expressed in adult human tissues, and there was a slightly reduced level of T48 transcripts that contained the Stop variant, indicating a degree of nonsense-mediated decay of these mRNAs. However, our finding of the apparently normal levels of an B48 kDa protein in CD patients who are homozygous for the Stop allele was unexpected. One possible explanation for this would be skipping of in-frame exons; however, we found no evidence for such transcripts. Another explanation would be initiation of translation from an alternative site downstream of rs2043211, but no such candidate AUG codons are apparent. A possible solution to this was provided by a detailed examination of the human EST database, which revealed six ESTs of an isoform with an initiation codon in intron 5, which would encode a 47.5 kDa protein with a unique N-terminal sequence; as it is initiated downstream of exon 5 in which the rs2043211 is located, it should not be affected by the presence of this variant. In the T54 isoform, the polymorphism would result in an amino-acid substitution (Phe4Ile) rather than a stop codon; although we detected expression of T54 mRNA in a range of normal tissues, western blot analysis revealed that, with the possible exception of one CD patient (090) who was homozygous for the Stop allele, the T54 protein isoform does not appear to be translated in the cell lines we tested, and is not generally expressed in normal tissues. Additional faint immunoreactive bands seen on the western blot may result from other isoforms of the protein, such as the inclusion of exon 4a, which would generate an B60 kDa protein when initiated from the T54 start codon in exon 4, or a 51 kDa protein when initiated from a start codon in exon 4a. In summary, the expected consequences of homozygosity for the Stop allele would therefore be loss of the T48 and T51 isoforms, expression of a mutated form of T54 and T60, but normal expression of T47 (Supplementary Figure 1) . Alternative splicing of mRNA can yield translation products that have different functions or localise to different cellular compartments. The two known and three novel protein isoforms of CARD8 described here differ from each other in their N-termini. Furthermore, as it is the N-terminal 320 amino acids of T48 that have been shown to be essential for inhibition of NF-kB signalling, 7 and as T48 and T54 have antagonistic effects on apoptosis, 7 we might expect all five isoforms to differ in their effects on the regulation of the immune response. In addition, recent immuno-histochemical analysis of CARD8 in non-smallcell lung cancer tissue revealed three patterns of localisation: exclusive cytoplasmic or nuclear localisation, or both cytoplasmic and nuclear localisation. 21 The antibody in this study was raised against a sequence that is present in all five isoforms of CARD8, and it is therefore possible that the antibody may be detecting different isoforms in different cellular compartments. The evolution of CARD8 is obscure. It is a paralogue of the C-terminal B400 amino acids of NALP1 (ie including the CARD domain but not the pyrin, NACHT or LRR regions of NALP1); indeed exons 7 -13 of all extant CARD8 genes share an identical gene structure with the corresponding region of NALP1 genes. Significant amino-acid homology to NALP1 commences two-thirds of the way through the exon 7 region of CARD8 and continues to its C-terminus. Most mammalian genome sequences examined (including the noneutherian mammals opossum and platypus) have a clearly defined NALP1 gene. CARD8, on the other hand, while present in primates, carnivores, xenarthrans and afrotherians, is missing from the completed genome sequences of rodents, cetartiodactyls and marsupials. In birds and amphibians a CARD8-like gene is observed, but no NALP1 orthologue is seen. This suggests that NALP1 arose from a fusion event between ancestral CARD8 and non-CARD-containing NALP genes, and that CARD8 genes were later lost on several occasions. A corollary of this complex and dynamic history is that sequences upstream of CARD8 exon 7 are poorly constrained and hard to identify. Dotplots reveal that although the introns and splice sites of CARD8 exons 4, 4a, 5 and 6 are conserved in marmoset and dog (for example), the exonic sequences themselves are barely recognisable, only their size and reading frame being conserved (Supplementary Figure 1 ). Findings in elephant and armadillo are very similar. Combined with other data, the most parsimonious assumption is that the long T54/T60 isoforms are ancestral but that functional constraint on amino-acid sequence upstream of exon 7 is either weak or subject to positive selection. Either way, it is clear that many mammalian species (including mouse, rat and cow) can function perfectly well without CARD8 genes.
In conclusion, this study demonstrates that individuals homozygous for a premature translation stop codon apparently affecting the 48 kDa major isoform of CARD8 nevertheless retain an B48 kDa immunoreactive protein.
In fact, 9% of the general population are homozygous for what appears to be a loss-of-function polymorphism in a gene that is likely to have a significant role in the immune response and apoptosis. This may reflect either some degree of redundancy in the functional pathways (notably, rodents do not have a CARD8 gene) or partial rescue of CARD8 function via alternative initiation of translation or splicing, leading to a functionally compromised but near full-length protein. This would be consistent with the presence of the B48 kDa protein that we observed in apparent homozygotes for the Stop allele (TT). Our bioinformatic analysis and expression studies of the CARD8 gene have provided evidence for the existence of three additional mRNA isoforms; T47, T51 and T60. The functional role of various isoforms of CARD8 is not yet clear, and warrants further investigation, as does the possible role of the Cys4Stop polymorphism. Finally, this study shows that a detailed characterisation of the effect of disease-associated sequence variants on gene expression can reveal unexpected outcomes that may be highly relevant to their contribution to pathogenesis.
